LOS ANGELES, CA--(Marketwire - Jan 30, 2012) - MMRGlobal, Inc. (
The Company will offer the EMR to MMRPro clients and other healthcare professionals. MMR will also demonstrate its MyMedicalRecords mobile app for tablets and smartphones, as well as its 4medica Live portal featuring direct online connectivity to pharmacy prescriptions and lab results delivered directly to an MMR subscriber's PHR. Also featured in booth #2062 at HIMSS will be MMR's new Telemedicine portal, which was introduced at the Consumer Electronics Show this month in the Alcatel-Lucent ngConnect booth, as well as its prepaid Personal Health Record card for distribution through hospitals and hospital gift shops. The Company also plans on distributing the prepaid Personal Health Record cards to pharmacies and other retailers throughout the United States.
Update on Taylor Armstrong
Over the past week, numerous articles have emerged in the national media that Bravo and cast members of "The Real Housewives of Beverly Hills" worry they will be dragged into the $1.5 million breach of contract lawsuit brought by MyMedicalRecords.com, Inc. against Russell and Taylor Armstrong. According to Bob Lorsch, CEO of MyMedicalRecords.com, Inc., MyMedicalRecords.com has had nothing to do with any such rumors. It simply intends to continue litigating its claims against the Armstrongs in the case.
However, tomorrow, MyMedicalRecords.com, Inc. plans on filing a Right to Attach Order against Taylor Armstrong in an effort to reserve her assets for collection of an eventual judgment. While media reports have claimed Russell Armstrong, who committed suicide last summer, left Taylor broke, MyMedicalRecords.com, Inc. believes the opposite is true and is therefore bringing the order. MyMedicalRecords.com filed suit against both Russell Armstrong and Taylor Armstrong on July 29, 2011 seeking damages of $1.5 million on claims the couple breached a previous Settlement Agreement. In 2007, two years before MyMedicalRecords.com, Inc. went public, it was discovered that the Armstrongs had misappropriated investor money and diverted shares of the Company's stock. Russell Armstrong, the largest shareholder at the time, was immediately removed from the board of directors and settled by giving up 100% of his equity position and payment of hundreds of thousands of dollars. Under the terms of the Settlement Agreement, signed by both Russell and his wife Taylor, the Armstrongs were required to identify everyone to whom they had sold shares of privately held MyMedicalRecords.com. However, the Armstrongs failed to do so, and MMR filed a $1.5 million breach of contract suit. MyMedicalRecords.com, Inc. is interested in Taylor's assets, income, book royalties, sponsor gifts, personal appearance fees and other income.
About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.
Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue." MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to MMRGlobal, Inc.'s business prospects, results of operations or financial condition; the risk and uncertainties inherent in litigation; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; competitive product offerings and promotions; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio; government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.
Contact Information:
CONTACT:
Michael Selsman
Public Communications Co.
(310) 922-7033
ms@publiccommunications.biz